Intravenous Ibuprofen Professional Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064673
  • May 2021
  • Pharmaceuticals
  • 118 Pages
The Intravenous Ibuprofen Professional Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt. Ltd., PT. Soho Industri Pharmasi, Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd, Al Nabeel International Ltd, Laboratorios Valmorca, C.A.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Intravenous Ibuprofen Professional market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Intravenous Ibuprofen Professional market is expected to attain Pre COVID-19 levels by mid-2022.

Intravenous Ibuprofen Professional Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Intravenous Ibuprofen Professional market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Intravenous Ibuprofen Professional Market Competitive and Premeditated Analysis
In the Intravenous Ibuprofen Professional report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Intravenous Ibuprofen Professional research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Intravenous Ibuprofen Professional Market:
The Intravenous Ibuprofen Professional market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt. Ltd., PT. Soho Industri Pharmasi, Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd, Al Nabeel International Ltd, Laboratorios Valmorca, C.A.

The Intravenous Ibuprofen Professional market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Intravenous Ibuprofen Professional Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Intravenous Ibuprofen Professional market:
By Type
Pain
Inflammatory
Fever
Age Group
Pediatrics
Adults

Regional Analysis of the Intravenous Ibuprofen Professional market:
The Intravenous Ibuprofen Professional market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Intravenous Ibuprofen Professional report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Intravenous Ibuprofen Professional market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Intravenous Ibuprofen Professional market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Intravenous Ibuprofen Professional market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Intravenous Ibuprofen Professional market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Intravenous Ibuprofen Professional market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Intravenous Ibuprofen Professional market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Intravenous Ibuprofen Professional market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Intravenous Ibuprofen Professional market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Cumberland Pharmaceuticals Inc.
  • Alveda Pharmaceuticals, Inc.
  • CSL Limited
  • Sandor Medicaids Pvt. Ltd.
  • PT. Soho Industri Pharmasi
  • Germin MED
  • Grifols S.A.
  • Harbin Gloria Pharmaceuticals Co., Ltd
  • Al Nabeel International Ltd
  • Laboratorios Valmorca, C.A.
  • Pain
  • Inflammatory
  • Fever
  • Pediatrics
  • Adults

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Intravenous Ibuprofen Professional Market Snapshot
          2.1.1. Global Intravenous Ibuprofen Professional Market By Type,2019
               2.1.1.1.Pain
               2.1.1.2.Inflammatory
               2.1.1.3.Fever
          2.1.2. Global Intravenous Ibuprofen Professional Market By Age Group,2019
               2.1.2.1.Pediatrics
               2.1.2.2.Adults
          2.1.3. Global Intravenous Ibuprofen Professional Market By End-use,2019
          2.1.4. Global Intravenous Ibuprofen Professional Market By Geography,2019

3. Global Intravenous Ibuprofen Professional Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Intravenous Ibuprofen Professional Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Intravenous Ibuprofen Professional Market Size (US$), By Type, 2018 – 2028

5. Global Intravenous Ibuprofen Professional Market Size (US$), By Age Group, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Age Group, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Age Group, 2020
     5.2. Global Intravenous Ibuprofen Professional Market Size (US$), By Age Group, 2018 – 2028

6. Global Intravenous Ibuprofen Professional Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Intravenous Ibuprofen Professional Market Size (US$), By End-use, 2018 – 2028

7. Global Intravenous Ibuprofen Professional Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Intravenous Ibuprofen Professional Market Analysis, 2018 – 2028 
          7.2.1. North America Intravenous Ibuprofen Professional Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Intravenous Ibuprofen Professional Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Intravenous Ibuprofen Professional Market Size (US$), By Age Group, 2018 – 2028
          7.2.4. North America Intravenous Ibuprofen Professional Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Intravenous Ibuprofen Professional Market Analysis, 2018 – 2028 
          7.3.1.  Europe Intravenous Ibuprofen Professional Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Intravenous Ibuprofen Professional Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Intravenous Ibuprofen Professional Market Size (US$), By Age Group, 2018 – 2028
          7.3.4. Europe Intravenous Ibuprofen Professional Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Intravenous Ibuprofen Professional Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Intravenous Ibuprofen Professional Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Intravenous Ibuprofen Professional Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Intravenous Ibuprofen Professional Market Size (US$), By Age Group, 2018 – 2028
          7.4.4. Asia Pacific Intravenous Ibuprofen Professional Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Intravenous Ibuprofen Professional Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Intravenous Ibuprofen Professional Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Intravenous Ibuprofen Professional Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Intravenous Ibuprofen Professional Market Size (US$), By Age Group, 2018 – 2028
          7.5.4. Latin America Intravenous Ibuprofen Professional Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Intravenous Ibuprofen Professional Market Analysis, 2018 – 2028 
          7.6.1.  MEA Intravenous Ibuprofen Professional Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Intravenous Ibuprofen Professional Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Intravenous Ibuprofen Professional Market Size (US$), By Age Group, 2018 – 2028
          7.6.4. MEA Intravenous Ibuprofen Professional Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Intravenous Ibuprofen Professional Providers
        8.4.1 Cumberland Pharmaceuticals Inc.
                8.4.1.1 Business Description
                8.4.1.2 Cumberland Pharmaceuticals Inc. Geographic Operations
                8.4.1.3 Cumberland Pharmaceuticals Inc. Financial Information
                8.4.1.4 Cumberland Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.1.5 Cumberland Pharmaceuticals Inc. Key Developments
        8.4.2 Alveda Pharmaceuticals, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Alveda Pharmaceuticals, Inc. Geographic Operations
                8.4.2.3 Alveda Pharmaceuticals, Inc. Financial Information
                8.4.2.4 Alveda Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.2.5 Alveda Pharmaceuticals, Inc. Key Developments
        8.4.3 CSL Limited
                8.4.3.1 Business Description
                8.4.3.2 CSL Limited Geographic Operations
                8.4.3.3 CSL Limited Financial Information
                8.4.3.4 CSL Limited Product Positions/Portfolio
                8.4.3.5 CSL Limited Key Developments
        8.4.4 Sandor Medicaids Pvt. Ltd.
                8.4.4.1 Business Description
                8.4.4.2 Sandor Medicaids Pvt. Ltd. Geographic Operations
                8.4.4.3 Sandor Medicaids Pvt. Ltd. Financial Information
                8.4.4.4 Sandor Medicaids Pvt. Ltd. Product Positions/Portfolio
                8.4.4.5 Sandor Medicaids Pvt. Ltd. Key Developments
        8.4.5 PT. Soho Industri Pharmasi
                8.4.5.1 Business Description
                8.4.5.2 PT. Soho Industri Pharmasi Geographic Operations
                8.4.5.3 PT. Soho Industri Pharmasi Financial Information
                8.4.5.4 PT. Soho Industri Pharmasi Product Positions/Portfolio
                8.4.5.5 PT. Soho Industri Pharmasi Key Developments
        8.4.6 Germin MED
                8.4.6.1 Business Description
                8.4.6.2 Germin MED Geographic Operations
                8.4.6.3 Germin MED Financial Information
                8.4.6.4 Germin MED Product Positions/Portfolio
                8.4.6.5 Germin MED Key Developments
        8.4.7 Grifols S.A.
                8.4.7.1 Business Description
                8.4.7.2 Grifols S.A. Geographic Operations
                8.4.7.3 Grifols S.A. Financial Information
                8.4.7.4 Grifols S.A. Product Positions/Portfolio
                8.4.7.5 Grifols S.A. Key Developments
        8.4.8 Harbin Gloria Pharmaceuticals Co., Ltd
                8.4.8.1 Business Description
                8.4.8.2 Harbin Gloria Pharmaceuticals Co., Ltd Geographic Operations
                8.4.8.3 Harbin Gloria Pharmaceuticals Co., Ltd Financial Information
                8.4.8.4 Harbin Gloria Pharmaceuticals Co., Ltd Product Positions/Portfolio
                8.4.8.5 Harbin Gloria Pharmaceuticals Co., Ltd Key Developments
        8.4.9 Al Nabeel International Ltd
                8.4.9.1 Business Description
                8.4.9.2 Al Nabeel International Ltd Geographic Operations
                8.4.9.3 Al Nabeel International Ltd Financial Information
                8.4.9.4 Al Nabeel International Ltd Product Positions/Portfolio
                8.4.9.5 Al Nabeel International Ltd Key Developments
        8.4.10 Laboratorios Valmorca, C.A.
                8.4.10.1 Business Description
                8.4.10.2 Laboratorios Valmorca, C.A. Geographic Operations
                8.4.10.3 Laboratorios Valmorca, C.A. Financial Information
                8.4.10.4 Laboratorios Valmorca, C.A. Product Positions/Portfolio
                8.4.10.5 Laboratorios Valmorca, C.A. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Intravenous Ibuprofen Professional Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Intravenous Ibuprofen Professional Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Intravenous Ibuprofen Professional Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Intravenous Ibuprofen Professional Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Intravenous Ibuprofen Professional Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Intravenous Ibuprofen Professional Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Intravenous Ibuprofen Professional Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Intravenous Ibuprofen Professional Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Intravenous Ibuprofen Professional Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Intravenous Ibuprofen Professional Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Intravenous Ibuprofen Professional Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Intravenous Ibuprofen Professional Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Intravenous Ibuprofen Professional Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Intravenous Ibuprofen Professional Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Intravenous Ibuprofen Professional Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Intravenous Ibuprofen Professional Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Intravenous Ibuprofen Professional: Market Segmentation 
FIG. 2 Global Intravenous Ibuprofen Professional Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Intravenous Ibuprofen Professional Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Intravenous Ibuprofen Professional Market, By Age Group, 2019 (US$ Mn) 
FIG. 6 Global Intravenous Ibuprofen Professional Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Intravenous Ibuprofen Professional Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Intravenous Ibuprofen Professional Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Intravenous Ibuprofen Professional Providers, 2019
FIG. 11 Global Intravenous Ibuprofen Professional Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Intravenous Ibuprofen Professional Market Revenue Contribution, By Age Group, 2019 & 2028 (Value %) 
FIG. 13 Global Intravenous Ibuprofen Professional Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Intravenous Ibuprofen Professional Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Intravenous Ibuprofen Professional Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Intravenous Ibuprofen Professional Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Intravenous Ibuprofen Professional Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Intravenous Ibuprofen Professional Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Intravenous Ibuprofen Professional market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Intravenous Ibuprofen Professional Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Intravenous Ibuprofen Professional Market Value, By Segment1, 2018 – 2028
TABLE  North America Intravenous Ibuprofen Professional Market Value, By Segment2, 2018 – 2028
TABLE  North America Intravenous Ibuprofen Professional Market Value, By Country, 2018 – 2028
TABLE  Europe Intravenous Ibuprofen Professional Market Value, By Segment1, 2018 – 2028
TABLE  Europe Intravenous Ibuprofen Professional Market Value, By Segment2, 2018 – 2028
TABLE  Europe Intravenous Ibuprofen Professional Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Intravenous Ibuprofen Professional Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Intravenous Ibuprofen Professional Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Intravenous Ibuprofen Professional Market Value, By Country, 2018 – 2028
TABLE  Latin America Intravenous Ibuprofen Professional Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Intravenous Ibuprofen Professional Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Intravenous Ibuprofen Professional Market Value, By Country, 2018 – 2028
TABLE  MEA Intravenous Ibuprofen Professional Market Value, By Segment1, 2018 – 2028
TABLE  MEA Intravenous Ibuprofen Professional Market Value, By Segment2, 2018 – 2028
TABLE  MEA Intravenous Ibuprofen Professional Market Value, By Country, 2018 – 2028
TABLE  Cumberland Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Alveda Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CSL Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sandor Medicaids Pvt. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  PT. Soho Industri Pharmasi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Germin MED: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Grifols S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Harbin Gloria Pharmaceuticals Co., Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Al Nabeel International Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Laboratorios Valmorca, C.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Intravenous Ibuprofen Professional Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Intravenous Ibuprofen Professional Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Intravenous Ibuprofen Professional Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Intravenous Ibuprofen Professional Market, By Geography, 2019 (US$ Mn)
FIG.  Global Intravenous Ibuprofen Professional Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Intravenous Ibuprofen Professional Providers, 2016
FIG.  Global Intravenous Ibuprofen Professional Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Inflammatory Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Fever Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Intravenous Ibuprofen Professional Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Adults Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Intravenous Ibuprofen Professional Market Value, 2018 – 2028, (US$ Mn)